11␤-Hydroxy (11␤-OH
G LUCOCORTICOIDS INHIBIT testosterone (T) biosynthesis in Leydig cells through a GR-mediated mechanism (1)
. Ligand-activated GR represses basal and cAMPinduced gene expression of T biosynthetic enzymes, leading to reduced T production (2, 3) . In Cushing's disease or during stress, exposure to excess glucocorticoid is associated with reduced circulating T levels and reproductive dysfunction (4 -7) . The glucocorticoid-metabolizing enzyme 11␤-hydroxysteroid dehydrogenase isoform 1 (11␤HSD1) catalyzes a reversible interconversion of active 11␤-OH-containing glucocorticoids [cortisol in humans and corticosterone (CORT) in rodents] and inert 11-keto forms (cortisone and 11-dehydro-CORT), and thus alters the Leydig cell's sensitivity to glucocorticoid inhibition of T biosynthesis (8 -11) .
Two isoforms of 11␤HSD (no. 1 and 2) have been characterized. 11␤HSD1 is a bidirectional enzyme, has a wide tissue distribution, and functions as either a dehydrogenase (CORT311-dehydro-CORT) or an oxidoreductase (11-dehydro-CORT3 CORT) in several tissues. In contrast, 11␤HSD2 functions as a unidirectional dehydrogenase that inactivates glucocorticoids (12) . Adult rat Leydig cells express high levels of 11␤HSD1 oxidative activity (8, 13) . However, in other glucocorticoid target tissues (e.g. liver and lung), 11␤HSD1 acts predominantly as a reductase and functions principally to locally regenerate active glucocorticoids from inactive 11-dehydro glucocorticoids (14) . Whether 11␤HSD1 is the only isoform present in Leydig cells is not yet certain, and it may be that 11␤HSD1 behaves differently in different glucocorticoid target tissues (15) (16) (17) . The physiological role played by 11␤HSD1 in Leydig cells is not fully understood. However, the bidirectional nature of 11␤HSD1 may well serve to control the magnitude of glucocorticoid action in this cell type.
The licorice derivative, glycyrrhetinic acid (GA), has been the most widely studied of the exogenous 11␤HSD inhibitors. Early studies by Monder and co-workers (8, 9) showed that inhibition of 11␤HSD1 oxidative activity in Leydig cells by GA increases the potency of CORT in suppression of T output. Recently, the 11␤-hydroxylated steroid derivative, 11␤-OH-progesterone (11␤-OH-Prog), has been shown to be as potent as GA in the inhibition of 11␤HSD oxidative activity (18, 19) . This discovery raises the possibility that locally produced 11␤HSD inhibitors, if they are synthesized in the testis, may affect the resultant Leydig cell 11␤HSD1 activity.
The early steps of steroidogenesis in adrenal and testis are common and consist of the sequential conversion of cholesterol to pregnenolone by cytochrome P450 side-chain cleavage and of prenenolone to progesterone by 3␤HSD. Subsequent to these steps, 21-hydroxylase catalyzes the conversion of Prog to DOC in the rat adrenal cortex, where mitochondrial 11␤-hydroxylase, specifically localized in the zona fasciculata, converts DOC to CORT.
In the present study we investigated whether 11␤-hydoxylase is present in Leydig cells and whether 11␤HSD1 dehydrogenase (or possibly even oxidoreductase) inhibitors can be synthesized in the testis. We report the presence of 11␤-hydroxylase mRNA, protein, and enzyme activity in rat Leydig cells. To further assess the physiological role of 11␤-hydroxylase, the inhibitory potencies of a variety of 11␤-OHand 11-keto-steroids on 11␤HSD1 activities (both dehydrogenase and oxidoreductase) in Leydig cells were measured, and several were found to be significant at nanomolar concentrations.
Materials and Methods Animals
Adult male Sprague Dawley rats, weighing 200 -250 g, were purchased from Charles River Laboratories, Inc. (Wilmington, MA). All animal procedures were approved by the institutional animal care and use committee of Rockefeller University (Protocol 91200-R2).
RT-PCR analysis of 11␤-hydroxylase (CYP11B1) mRNA
Purified Leydig cells were isolated from adult rat testes as described previously (20) . Cell preparations were judged to be more than 95% pure by histochemical staining for the Leydig cell-specific marker 3␤HSD (21) . The adrenal gland and uterus were used as positive and negative controls, respectively. Total RNA was extracted by a single step procedure using phenol/guanidinium isothiocyanate (Molecular Research Center, Inc., Cincinnati, OH). RNA samples were retained for analysis if the OD 260/280 ratio was above 1.8. First strand cDNA was transcribed using AMV reverse transcriptase (Promega Corp., Madison, WI).
PCR using the specific primer pair, 5Ј-GCTGGAGAATGTTC-ATGG-3Ј and 5Ј-CTCTGCCAGTTCGCGATA-3Ј, was prepared with sequences as previously published (22) and resulted in a 312-bp fragment corresponding to nucleotides 528 -840 of rat adrenal CYP11B1 cDNA. Amplification of the PCR products was performed under identical conditions, with a total of 30 cycles by denaturation at 94 C for 30 sec, primer annealing at 60 C for 1 min, and extension at 72 C for 1 min. PCR products were analyzed by electrophoresis on 1.5% agarose gels and submitted to Rockefeller University Protein DNA Technology Center for automated sequence analysis.
Localization of 11␤-hydroxylase by immunohistochemistry
After being perfused with Bouin's fixative solution, the testes and adrenal glands were postfixed overnight in the same fixative solution, then embedded in paraffin. Antigen retrieval was carried out by microwave treatment for 10 min in 10 mm (pH 6.0) citrate buffer before immunostaining. Endogenous peroxidase activity was quenched by incubation with 0.3% H 2 O 2 in absolute methanol for 20 min. Specific mouse antirat 11␤-hydroxylase monoclonal antibody (Chemicon International, Inc., Temecula, CA) was used at a 1:300 dilution overnight at 4 C. Antibody-antigen complexes were detected using a Vectastain Elite ABC kit (Vector Laboratories, Inc., Burlingame, CA). The specificity of the antibody was assessed by positive staining in the zona fasciculata of the adrenal cortex (23) and lack of staining when the primary antibody was substituted by nonimmune mouse IgG. Localization in Leydig cells was also confirmed after their elimination from the testis using ethane dimethane sulfonate (EDS) (24) .
Western blot assay with 11␤-hydroxylase antibody
Purified Leydig cells and adrenal cortex were homogenized in 3 vol ice-cold lysis buffer (1 ϫ PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 100 g/ml phenylmethylsulfonylfluoride, and 30 l/ml aprotinin) and then centrifuged at 15,000 ϫ g for 15 min at 4 C. Supernatants were collected and centrifuged twice. Protein concentrations were measured by the Bradford assay using a kit (Bio-Rad Laboratories, Inc., Hercules, CA). Aliquots of the detergent extracts (30 g adrenal cortex and 100 g Leydig cells) were subjected to 10% SDS-PAGE. Proteins were transferred electrophoretically onto nitrocellulose membranes (Schleicher & Schuell, Inc., Keene, NH). The blots were probed with the same antibody that was used for immunohistochemistry. The resulting bands were visualized by chemiluminescence (Santa Cruz Biotechnology, Inc., Santa Cruz, CA).
Assay of 11␤-hydroxylase activity in Leydig cells
11␤-Hydroxylase activity was evaluated by measuring the rate of conversion of DOC to CORT. The reaction mixture was prepared in phenol red-free Leydig cell medium that contained [ 3 H]DOC at final concentrations ranging from 1-150 m. Triplicate samples were preincubated for 10 min at 34 C, 0.2 ϫ 10 6 cells were added, and incubation was continued for 2 h. Reactions were terminated by adding ice-cold ether to the mixture. Steroids were then extracted twice with ether, the organic layer was dried under nitrogen, and the residues were analyzed by HPLC. Elution was monitored simultaneously at 240 nm with a variable wavelength detector and a flow scintillation analyzer (Packard 500 TR series, Downers Grove, IL). The stationary phase was an ODS column (Chromegabond MC18, 5 m, 50 A, 25 cm, 4.6 cm). The mobile phase consisted of tetrahydrofuran/methanol/water (120:100:180), and the flow rate was 1 ml/min. Under these conditions, DOC and its possible metabolites, CORT, 11-dehydro-CORT, and aldosterone, eluted at 6.5, 5.9, 5, and 4 min, respectively.
Formation of CORT by purified intact Leydig cells was evaluated further using gas chromatography/mass spectrometry (GC/MS) by Dr. Cedric H. Shackleton (Children's Hospital-Oakland Research Institute, Oakland, CA). The incubation was conducted as described above, but with 5 m DOC in 50 ml culture medium containing 25 ϫ 10 6 cells for 4 h. Methyloxime-trimethylsilyl ethers were made of the extracts before GC/MS analysis, which was carried out on a Hewlett-Packard Co. 5971 MSD instrument housing a nonpolar capillary column. The extracts were introduced by splitless injection, and the oven temperature was programmed to rise from 220 to 320 C during the run. Scanning was conducted over a 100 -650 amu mass range.
Determination of kinetic constants
Kinetic analysis was performed by fitting initial velocity data as a function of substrate concentration to the Michaelis-Menten equation with EnzFitter, a nonlinear curve-fitting program (Biosoft, Ferguson, MO).
Assay of 11␤HSD enzyme kinetics and directionality in Leydig cells
Experiments were conducted with either intact cells or homogenates prepared from purified rat Leydig cells. In intact Leydig cells, the inhibitory activities of 11␤-OH-Prog and 11␤-OH-T as well as their 11-keto derivatives were assessed by incubating intact Leydig cells (containing 56,000 or 100,000 cells) in cell culture medium with 25 (25, 26) as substrate at 34 C for 10 min.
Purified rat Leydig cells were homogenized in 25 mm HEPES buffer (pH 7.4) and rehomogenized after addition glycerol. 11␤HSD1 activities were assayed by incubating homogenates (13,000 cells equivalent) with 100 nm [ 3 H]CORT in the presence of 3 mm NADP or homogenates (52,000 cells equivalent) with 600 nm [ 3 H]11-dehydro-CORT in the presence of 3 mm NADPH at 37 C for 30 min. The reactions were stopped by the addition of methanol and centrifuged, and the steroid present in the supernatant was separated by HPLC using a DuPont Zorbax C 8 column. The separated radioactive products (CORT and 11-dehydro-CORT) were detected and quantitated by flow scintillation analysis. The assay was conducted in the presence of varying concentrations (0.1-100 m) of 11␤-OH-Prog, 11keto-Prog, 11␤-OH-T, 11-keto-T, 11␤-OH-AD, 11-keto-AD, 11␤-OH-dehydroepiandrosterone (11␤-OH-DHEA), T, or 3␣,5␣-metabolite of T (3␣,5␣-OH-THT; Steraloids, Newport, RI) for assessing IC 50 values against 11␤HSD1 activity (both dehydrogenase and oxidoreductase).
Data analysis
Each experiment was repeated at least three times using three independently extracted RNA, protein, and tissue samples from different animals. The IC 50 value was used for analysis of inhibitory activity of steroids on enzyme activity.
Results

Detection of CYP11B1 mRNA in purified rat Leydig cells
Gel electrophoresis (Fig. 1A) revealed a 312-bp PCR fragment for CYP11B1 in Leydig cells and the adrenal gland, but not in uterus. The bands corresponding to CYP11B1 in Leydig cells were fainter than those in the adrenal gland. The identities of the PCR products were confirmed by sequencing. There was 100% concordance between the observed and predicted bases at the diagnostic CYP11B1 nucleotides (27) . These results confirmed that CYP11B1 gene transcripts are present in Leydig cells.
Localization of 11␤-hydroxylase in rat testis
11␤-Hydroxylase protein localization in the testis was studied by immunohistochemistry, which provided evidence that 11␤-hydroxylase immunoreactivity was selectively localized in Leydig cells (Fig. 2C) , because the testicular 11␤-hydroxylase immunoreactivity disappeared in animals treated with EDS, a drug that selectively destroys Leydig cells (Fig. 2D) . The method was validated by testing the specificity of the antibody in the adrenal cortex, which showed the expected distribution of 11␤-hydroxylase immunoreactivity restricted to the zona fasciculata ( Fig. 2A) . Immunostaining was not seen in negative control sections in which the primary antibody was replaced by nonimmune mouse IgG (Fig. 2B) . Furthermore, after SDS-PAGE and immunoblotting, the anti-11␤-hydroxylase antibody identified a protein band with a relative molecular mass of 51.5 kDa in both Leydig cells and adrenal cortex (Fig. 1B) , which was consistent with the published molecular mass of rat adrenal 11␤-hydroxylase (28) . The intensity of 11␤-hydroxylase immunoreactivity in Leydig cells was lower than that in adrenal cortex.
Biochemical characteristics of 11␤-hydroxylase in Leydig cells
Purified Leydig cells were incubated with tritium-labeled DOC for timed intervals in the presence of increasing concentrations of substrate. A Michaelis-Menten relationship between the concentration of substrate and the rate of product formation was observed, with the K m for CORT synthesis being 7.28 Ϯ 0.92 m, and the maximum velocity equal to 1.13 Ϯ 0.04 mol/10 6 cells⅐h (Fig. 3) . Synthesis of CORT from DOC was also confirmed by GC/ MS. The molecular ion of CORT is at m/z 548, and loss of the oxime is seen at m/z 517. A peak in the analyzed incubate possessed a mass spectrum and retention time identical to that of the CORT standard. These results showed that there was a sufficient amount of 11␤-hydroxylase in Leydig cells to biosynthesize 11␤-OH compounds.
Effects of 11␤-hydroxylated steroids on 11␤HSD1 activity in Leydig cells
In cell homogenates, the 11␤-OH compounds inhibited 11␤HSD1 dehydrogenase reaction with a hierarchy of inhibitory activities in order of decreasing potency: 11␤-OHProg Ͼ 11␤-OH-T Ͼ 11␤-OH-AD, with corresponding IC 50 values of 0.4, 1.7, and 70.0 m, respectively. In contrast, their corresponding 11-keto derivatives were inactive as inhibitors of dehydrogenase activity with IC 50 values of greater than 100 m and suppressed the oxidoreductase reaction of 11␤HSD1 with IC 50 values of 9.5, 18, and 21 m, respectively (Table 1 ). In contrast, the 11␤-OH compounds were relatively inactive with respect to 11␤HSD1 oxidoreductase activities, with IC 50 values exceeding 100 m.
Of the other hydroxylated compounds tested, 11␤-OH-DHEA (a ⌬ 5-6 compound) inhibited 11␤HSD1 dehydrogenase activity with an IC 50 value of 3.3 m and oxidoreductase activity with an IC 50 value greater than 100 m. T, which possesses no 11-OH function, inhibited both forward and backward enzymatic reactions of 11␤HSD, with IC 50 values of 20 and 33 m, respectively. 3␣,5␣-THT was more potent than the parent compound, T, with IC 50 values of 6.1 and 20.0 m for the dehydrogenase and oxidoreductase activities, respectively (Table 1 ). This implies that 5␣ ring reduction of T increased its inhibitory potency relative to that of the parent steroid hormone, T.
When incubated with the whole cell preparations, in which much lower concentrations of substrates were used, 11␤-OH-T was a more potent inhibitor of 11␤HSD1 for the oxidative reaction compared with 11␤-OH-Prog, with IC 50 values of 30 vs. 65 nm. However, the 11-keto derivatives were equally potent inhibitors of oxidoreductase activity in whole cell preparations, with IC 50 values of 1.4 and 1.5 m, respectively ( Table 2 ). The inhibitory activity in whole cells was more potent compared with results obtained in the homogenate preparations.
Discussion
The predominant catalytic activity of 11␤HSD1 locally controls the magnitude of glucocorticoid action in testis. By acting as a dehydrogenase it may serve to protect Leydig cells from the effects of excessive glucocorticoids. In contrast, by acting as an oxidoreductase, 11␤HSD1 could enhance glucocorticoid action by reactivation of 11-dehydroglucocorticoid back to active glucocorticoid. The biochemical determinants of the direction of the 11␤HSD1 reaction are not fully understood. The overall 11␤HSD1 activity in Leydig cells is most likely modulated by a variety of biochemical mechanisms, including different levels of enzyme expression, co- factor concentration, and redox state. The licorice derivative, GA, is a potent inhibitor of both 11␤HSD1 and 11␤HSD2 dehydrogenase as well as a moderate inhibitor of 11␤HSD1 oxidoreductase (29, 30 ). An increasing body of evidence indicates that some endogenously synthesized 11␤-hydroxylated derivatives of steroids, such as 11␤-OH-Prog, originally described as an inhibitor of placental 11␤HSD are potent inhibitors of both 11␤HSD1 and 11␤HSD2 dehydrogenase (19, 31) . Earlier experiments have shown that 11␤-OH-Prog inhibited 11␤HSD1 dehydrogenase, and 11-keto-Prog inhibited 11␤HSD1 oxidoreductase in vascular smooth muscle cells (32, 33) . Rat testicular Leydig cell preparations display both dehydrogenase and oxidoreductase enzymatic activities of this enzyme, and to date, only 11␤HSD1 mRNA and protein have been shown to be present (15) (16) (17) . In this study we considered the possibility that endogenous 11␤HSD inhibitors are synthesized in the testis and investigated whether 11␤-oxygenated products derived from progesterone, T, DHEA, or androstenedione inhibit either rat Leydig cell 11␤HSD1 dehydrogenase or oxidoreductase activity.
We have now demonstrated that 11␤-hydroxylase gene transcripts and immunoreactivity are selectively localized in rat Leydig cells by RT-PCR and immunohistochemistry, which was further confirmed by sequencing and the Western blot results. Extraadrenal expression of 11␤-hydroxylase in benign Leydig cell tumors and in eel testes has been reported previously (34, 35) . This enzyme is also found in blood vessels, heart, and brain (36 -39) . Taken together, the selective localization of 11␤-hydroxylase in Leydig cells suggests that the enzymatic machinery necessary for local production of 11␤-oxygenated inhibitory substances from steroids is present in the testis.
11␤-Hydroxylase gene transcription and protein expression do not provide unequivocal evidence that a functional protein is present. However, the results of the HPLC analysis demonstrate 11␤-hydroxylase catalytic activity in Leydig cells, and CORT formation was further confirmed by GC/MS analysis. These results further support the hypothesis that Leydig cells have the potential to synthesize other 11␤-OHsteroid intermediates via local 11␤-hydroxylation. The presence of 11␤-OH-Prog and 11-keto-Prog in venous drainage from the adrenal gland and in humans under the clinical condition of 17-hydroxylase deficiency provides evidence for synthesis of 11␤-OH-steroid intermediates in vivo (40, 41) . The potential for Leydig cells to biosynthesize CORT remains to be established, because a complete synthetic pathway for CORT requires 21-hydroxlase, and expression of this enzyme has not been detected in the testis. It is also possible that adrenal-derived precursors such as DOC will act as substrates for 11␤-hydroxylase in the testis.
In this study we further investigated the effects and relative potencies of several 11␤-OH-steroids and their corresponding 11-keto derivatives on 11␤HSD1 oxidative and reductive activities of Leydig cell homogenates and intact Leydig cells using either CORT or 11-dehydro-CORT as substrates. The 11␤-OH-steroid intermediates, which are logical candidates for locally generated 11␤HSD inhibitors, are capable of inhibiting testicular 11␤HSD1 activity in a directionally specific manner, blocking the 11␤HSD1 dehydrogenase reaction. In contrast, several of the 11-keto compounds inhibited only the oxidoreductase reaction, as expected (18, 19) . Similar patterns of directionally specific inhibition and more potent inhibitory activities were observed with several of these substances in whole Leydig cells. At this time, the mechanism of inhibition due to these substances is unknown. The results are consistent with previous studies in vascular tissue, in which 11␤-OH-or 11-ketosteroids have a significant influence on both 11␤HSD1 activity and the resultant vasoconstrictivity in response to catecholamines, which is enhanced by both CORT and 11-dehydro-CORT (32, 33) . GA-mediated inhibition of Leydig cell 11␤HSD1 dehydrogenase enhances the ability of CORT to suppress T production (8) . These results also suggest the possibility that individual 11␤-OH-steroid derivatives may function as GA does in the testis, with the potential to augment the responses of Leydig cells to CORT through inhibition of testicular 11␤HSD1 dehydrogenase activity. Conversely, certain 11-keto-steroid derivatives may operate in the rat to diminish the responses of Leydig cells to glucocorticoids by lessening the ability to regenerate active glucocorticoids from 11-dehydroglucocorticoids.
11␤-Hydroxylase expression and activity are lower in Leydig cells than in the adrenal cortex. However, small amounts of locally produced inhibitory substances, could exert significant physiological effects on glucocorticoid regulation of T biosynthesis, as Leydig cells are highly sensitive to regulation by CORT. In the present study 11␤-OH-T showed stronger inhibition of 11␤HSD1 oxidative activity compared with 11␤-OH-Prog in whole Leydig cells, indicating that the testicular 11␤HSD1 could be highly sensitive to regulation by locally produced 11␤HSD inhibitors. The present study suggests that T itself may inhibit 11␤HSD oxidative activity due to its high concentration in the testicular interstitium. A local negative feedback system may thereby control T production in the testis through increased inhibitory action of glucocorticoid on T biosynthesis. Local production of 5␣-reduced products of T may play a similar role.
The physiological function of 11␤-hydroxylase in the testis is still unknown. However, local testicular synthesis of 11␤HSD1 inhibitors may provide another control point in stress-induced reproductive dysfunction. The evidence supports the hypothesis that the stress hormones, ACTH and glucocorticoid, attenuate 11␤HSD1 dehydrogenase activity in the testis (5, 42, 43) . As adrenal 11␤-hydroxylase is regulated by ACTH, which is increased during stress, it will be of interest to determine whether this hormone stimulates levels of 11␤-hydroxylase in Leydig cells, inhibiting 11␤HSD1 and contributing to stress-mediated declines in T production (6) . This may further explain why 11␤HSD1 is unable to fully protect the testis from the deleterious effects of glucocorticoid action in Cushing's syndrome and during severe stress.
In summary, 11␤-hydroxylase mRNA, protein and activity are expressed in rat Leydig cells. The occurrence of steroid 11␤-hydroxylation in these cells raises the possibility that endogenous inhibitory substances of 11␤HSD are synthesized in the testis, affecting overall CORT action through control of bidirectional 11␤HSD1 activity.
